A local company plans to produce up to 8,500 kilograms of medical marijuana every year once production begins in Cranbrook.
Dycar Pharmaceuticals announced last week they purchased a 86,000 square foot location in the industrial park, with plans to increase total space to over 114,000 square feet.
VP of Sales and Marketing Carmen Wannop says the cannabis would supply patients across Canada with a prescription.
“Medical cannabis we can supply to any patient across Canada,” Wannop says. “So what they will do is come to our website, place their orders once we verify their prescription and then the order gets sent directly to them to their door.”
She says City Council has been supportive of the project since it began.
“We contacted Cranbrook literally the morning they were changing the bylaws,” Wannop says. “We knew about this building, this building fit and right from day one, the city has completely backed us with everything.”
Dycar Pharmaceuticals expects to be up and running by June of this year and plans to hire 200 people.
Wannop says they will likely invest over $35 million establishing their facility in the Key City.
– Carmen Wannop, VP of Sales and Marketing, Dycar Pharmaceuticals